Patent · US Active

Assays for BTK inhibitors

US10012650B2 · kind B2 · utility

0Cited by

9References

4Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Andrew Bender · Reading, US
Lesley Liu-Bujalski · Bedford, US
Albertina Pereira · Bedford, US
Richard D. Caldwell · Melrose, US
Roland Grenningloh · Arlington, US
Daigen Xu · Ottawa, CA

Key dates

Filing date	Dec 10, 2015
Grant date	Jul 3, 2018
Priority date	—
Expiry date	Dec 10, 2035

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/02
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to BTK occupancy assays.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.